What Is the Risk of Preterm Delivery after Arrested Preterm Labor?

Abstract

Objective The aim of this study is to assess if women with arrested preterm labor (PTL) have an increased risk of preterm delivery (PTD) compared with healthy pregnant women, and if digital examination, fetal fibronectin (fFn) and cervical length (CL) are prognostic markers for PTD after arrested PTL.

Study Design Prospective-matched cohort study among women with arrested PTL (cases) and healthy pregnant women (controls).

Results We included 74 index cases and 74 controls. PTD occurred in 20 (27%) index cases and in 5 (7%) controls (hazard ratio [HR], 4.5; 95% confidence interval [CI], 1.7–12). A dilatation of the cervix ≥ 1 cm (HR, 9.1 [95% CI, 3.3–25], an fFn positive status (HR, 13 [95% CI, 4.3–40]), and a CL < 15 mm (HR, 11 [95% CI, 3.1–38]) increased this risk in cases compared with controls. Knowledge of the fFn result had additional value over the cervical dilatation or CL in the prediction of persistent PTD, with an increased risk in case of a positive fFn test.

Conclusion Women stay at increased risk for PTD after arrested PTL. This risk further increased in case of ≥ 1 cm cervical dilatation, CL < 15 mm and/or a positive fFn status.

Keywords

arrested preterm labor - cervical length - fetal fibronectin - preterm delivery

Note

This study has been presented at the Society for Maternal Fetal Medicine 31th Annual Meeting in San Francisco, February 11, 2011.

• References

• 1 NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995; 273 (5) 413-418
• 2 Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360 (9344) 1489-1497
• 3 Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol 2003; 101 (2) 402-412
• 4 King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003; (1) CD002255
• 5 Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005; (3) CD004452
• 6 Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50 (4) 515-525
• 7 Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97 (1) 11-25
• 8 Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173 (1) 322-335
• 9 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; (3) CD004454
• 10 DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013; 208 (3) e1-e6
• 11 Gomez R, Romero R, Medina L , et al. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol 2005; 192 (2) 350-359
• 12 Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol 2009; 114 (3) 631-640
• 13 McPheeters ML, Miller WC, Hartmann KE , et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192 (4) 1325-1329 , discussion 1329–1330
• 14 Onderoğlu LS. Digital examination and transperineal ultrasonographic measurement of cervical length to assess risk of preterm delivery. Int J Gynaecol Obstet 1997; 59 (3) 223-228
• 15 Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002; 325 (7359) 301
• 16 Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 2003; 22 (3) 305-322
• 17 Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol 2010; 35 (1) 54-64
• 18 Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A, McNellis D ; NICHD Maternal Fetal Medicine Units Network. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996; 87 (5 Pt 1): 643-648
• 19 Wiegerinck MM, Vis JY, Mol BW. Re: Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol 2010; 35 (6) 756-757 , author reply 756–757
• 20 Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor. Ultrasound Obstet Gynecol 2006; 27 (4) 368-372
• 21 Schmitz T, Maillard F, Bessard-Bacquaert S , et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol 2006; 194 (1) 138-143
• 22 Wilms FF, van Stralen G, Porath MM , et al. Predicating imminent preterm labour based on a determination of foetal fibronectin in a vaginal smear [in Dutch]. Ned Tijdschr Geneeskd 2009; 153: B398
• 23 Dutch Medical Research Available at: http://www.ccmo.nl/en/your-research-does-it-fall-under-the-wmo
• 24 Schaaf JM, Mol BW, Abu-Hanna A, Ravelli AC. Trends in preterm birth: singleton and multiple pregnancies in the Netherlands, 2000-2007. BJOG 2011; 118 (10) 1196-1204
• 25 Arnon S, Dolfin T, Litmanovitz I, Regev R, Bauer S, Fejgin M. Preterm labour at 34–36 weeks of gestation: should it be arrested?. Paediatr Perinat Epidemiol 2001; 15 (3) 252-256
• 26 Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics 2004; 114 (2) 372-376
• 27 Adams-Chapman I. Neurodevelopmental outcome of the late preterm infant. Clin Perinatol 2006; 33 (4) 947-964 , abstract xi
• 28 Tomashek KM, Shapiro-Mendoza CK, Davidoff MJ, Petrini JR. Differences in mortality between late-preterm and term singleton infants in the United States, 1995-2002. J Pediatr 2007; 151 (5) 450-456 , e1
• 29 Ramachandrappa A, Jain L. Health issues of the late preterm infant. Pediatr Clin North Am 2009; 56 (3) 565-577
• 30 Engle WA, Kominiarek MA. Late preterm infants, early term infants, and timing of elective deliveries. Clin Perinatol 2008; 35 (2) 325-341 , vi
• 31 Yost NP, Bloom SL, McIntire DD, Leveno KJ. Hospitalization for women with arrested preterm labor: a randomized trial. Obstet Gynecol 2005; 106 (1) 14-18
• 32 Goulet C, Gévry H, Lemay M , et al. A randomized clinical trial of care for women with preterm labour: home management versus hospital management. CMAJ 2001; 164 (7) 985-991
• 33 Sosa C, Althabe F, Belizán J, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 2004; (1) CD003581
• 34 Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. Efficacy of maintenance therapy after acute tocolysis: a meta-analysis. Am J Obstet Gynecol 1999; 181 (2) 484-490
• 35 Roos C, Spaanderman ME, Schuit E , et al; APOSTEL-II Study Group. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial. JAMA 2013; 309 (1) 41-47
• 36 Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2010; (7) CD000940
• 37 Nanda K, Cook LA, Gallo MF, Grimes DA. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev 2002; (4) CD003933
• 38 Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev 2009; (1) CD005938 Review
• 39 Borna S, Sahabi N. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol 2008; 48 (1) 58-63
• 40 Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 2007; 196 (5) e1-e4 , discussion 421
• 41 Tita AT, Rouse DJ. Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol 2009; 200 (3) 219-224
• 42 Rozenberg P, Chauveaud A, Deruelle P , et al; Groupe De Recherche En Obstétrique et Gynécologie. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Am J Obstet Gynecol 2012; 206 (3) e1-e9